Inventor · disambiguated record
William J. Boyle
Also filed as: BOYLE JR WILLIAM J · BOYLE WILLIAM · BOYLE WILLIAM J · BOYLE WILLIAM JAMES
35 granted patents·21 pending applications·1,291 citations·filing 1974–2023
98Inventor score
Top patents by PatentIndex Score
56 records- 0198US8058418B2Polynucleotides encoding heavy and light chains of antibodies to OPGLBOYLE WILLIAM J·Filed 2007·Granted Nov 15, 2011·40 cites·40 claims
- 0298US7364736B2Antibodies to OPGLAMGEN INC·Filed 2002·Granted Apr 29, 2008·97 cites·25 claims
- 0396US6015938AOsteoprotegerinAMGEN INC·Filed 1997·Granted Jan 18, 2000·158 cites·2 claims
- 0495US7097834B1Osteoprotegerin binding proteinsAMGEN INC·Filed 1998·Granted Aug 29, 2006·102 cites·31 claims
- 0595US6284485B1Nucleic acids encoding osteoprotegerinAMGEN INC·Filed 1997·Granted Sep 4, 2001·123 cites·16 claims
- 0695US5843678AOsteoprotegerin binding proteinsAMGEN INC·Filed 1997·Granted Dec 1, 1998·138 cites·15 claims
- 0794US7923008B2Methods for decreasing osteoclast formation or bone resorption using an antibody to osteoprotegerin binding proteinAMGEN INC·Filed 2006·Granted Apr 12, 2011·27 cites·34 claims
- 0893US6316408B1Methods of use for osetoprotegerin binding protein receptorsAMGEN INC·Filed 1998·Granted Nov 13, 2001·89 cites·9 claims
- 0992US7718776B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsAMGEN INC·Filed 2003·Granted May 18, 2010·47 cites·50 claims
- 1091US6288032B1OsteoprotegerinAMGEN INC·Filed 1997·Granted Sep 11, 2001·56 cites·14 claims
- 1190US8409578B2Methods for treating bone loss with antibodies to OPGLBOYLE WILLIAM J·Filed 2011·Granted Apr 2, 2013·4 cites·36 claims
- 1290US6284728B1OsteoprotegerinAMGEN INC·Filed 1997·Granted Sep 4, 2001·57 cites·9 claims
- 1390US6284740B1OsteoprotegerinAMGEN INC·Filed 1997·Granted Sep 4, 2001·56 cites·20 claims
- 1489US6521422B1Fhm, a novel member of the TNF ligand supergene familyAMGEN INC·Filed 2000·Granted Feb 18, 2003·34 cites·12 claims
- 1587US9856323B2Anti-CD22 antibodiesBIOATLA LLC·Filed 2013·Granted Jan 2, 2018·10 cites·22 claims
- 1686US6369027B1OsteoprotegerinAMGEN INC·Filed 1996·Granted Apr 9, 2002·65 cites·19 claims
- 1786US5824303AEck receptor ligandsAMGEN INC·Filed 1995·Granted Oct 20, 1998·61 cites·8 claims
- 1885US7005413B1Combination therapy for conditions leading to bone lossAMGEN INC·Filed 2000·Granted Feb 28, 2006·16 cites·15 claims
- 1979US6613544B1OsteoprotegerinAMGEN INC·Filed 1995·Granted Sep 2, 2003·20 cites·13 claims
- 2078US2024141035A1Anti-Il-22 Antibodies, Antibody Fragments,Their Immunoconjugates And Uses ThereofBIOATLA INC·Filed 2023·Application pending·0 cites
- 2176US7544519B2Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulatorsAMGEN INC·Filed 2004·Granted Jun 9, 2009·8 cites·25 claims
- 2275US2020354464A1Antibodies to opglAMGEN INC·Filed 2020·Application pending·0 cites
- 2374US7807795B2Antibodies to osteoprotegerin binding proteinsAMGEN INC·Filed 1998·Granted Oct 5, 2010·23 cites·11 claims
- 2472US7632922B1OsteoprotegerinAMGEN INC·Filed 2000·Granted Dec 15, 2009·1 cites·11 claims
- 2572US2020131271A1Antibodies to opglAMGEN INC·Filed 2020·Application pending·0 cites
- 2670US5650504ANucleic acids encoding eck receptor ligandsAMGEN INC·Filed 1995·Granted Jul 22, 1997·24 cites·6 claims
- 2769US6852839B2Fhm, a novel member of the TNF ligand supergene familyAMGEN INC·Filed 2002·Granted Feb 8, 2005·3 cites·20 claims
- 2869US2014134157A1Antibodies to opglAMGEN INC·Filed 2013·Application pending·0 cites
- 2968US2017183417A1Antibodies to opglAMGEN INC·Filed 2016·Application pending·0 cites
- 3067US11834472B2Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2019·Granted Dec 5, 2023·0 cites·29 claims
- 3166US6479250B1Eck receptor ligandsAMGEN INC·Filed 2000·Granted Nov 12, 2002·2 cites·9 claims
- 3265US4062839AResolution of α-amino-e-caprolactam optical isomersALLIED CHEM·Filed 1976·Granted Dec 13, 1977·4 cites·5 claims
- 3364US2015266952A1Antibodies to opglAMGEN INC·Filed 2015·Application pending·0 cites
- 3463US3941776AResolution/racemization of aminolactam compoundsALLIED CHEM·Filed 1974·Granted Mar 2, 1976·5 cites·21 claims
- 3563US2010298229A1OsteoprotegerinAMGEN INC·Filed 2009·Application pending·0 cites
- 3660US2005221331A1OsteoprotegerinAMGEN INC·Filed 2004·Application pending·0 cites
- 3760US2013171168A1Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway InhibitorsAMGEN INC·Filed 2013·Application pending·0 cites
- 3860US2013164292A1Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway InhibitorsAMGEN INC·Filed 2012·Application pending·0 cites
- 3959US8455629B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsBOYLE WILLIAM J·Filed 2012·Granted Jun 4, 2013·0 cites·18 claims
- 4059US5716934AEck receptor ligandsAMGEN INC·Filed 1995·Granted Feb 10, 1998·13 cites·17 claims
- 4159US4259239AResolution of enantiomeric complexes of nickelous chloride and alpha-aminocaprolactamALLIED CHEM·Filed 1980·Granted Mar 31, 1981·4 cites·4 claims
- 4259US2008107597A1Isolation of antibodies that cross-react and neutralize rankl originating from multiple speciesANAPTYS BIOSCIENCES INC·Filed 2007·Application pending·0 cites
- 4358US2005003400A1Osteoprotegerin binding proteins and receptorsAMGEN INC·Filed 2004·Application pending·0 cites
- 4456US8367063B2Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitorsAMGEN INC·Filed 2010·Granted Feb 5, 2013·0 cites·32 claims
- 4556US3988320ASingle stage resolution/racemization of α-amino-ε-caprolactamALLIED CHEM·Filed 1975·Granted Oct 26, 1976·3 cites·12 claims
- 4653US2010209435A1Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway InhibitorsAMGEN INC·Filed 2010·Application pending·0 cites
- 4750US2005147611A1Combination therapy for conditions leading to bone lossAMGEN INC·Filed 2005·Application pending·0 cites
- 4850US2014147444A1Selective binding agents of osteoprotegerin binding proteinAMGEN INC·Filed 2013·Application pending·0 cites
- 4948US2018086843A1Anti-cd22 antibodiesBIOATLA LLC·Filed 2017·Application pending·0 cites
- 5045US2003103978A1Selective binding agents of osteoprotegerin binding proteinAMGEN INC·Filed 2001·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William J. Boyle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →